Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential

The emergence of Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV) led to a rapid response not only to contain the outbreak but also to identify possible therapeutic interventions, including the generation of human monoclonal antibodies (hmAbs). hmAbs may be used therapeutically without the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Coughlin, Melissa M., Prabhakar, Bellur S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2011
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256278/
https://www.ncbi.nlm.nih.gov/pubmed/21905149
http://dx.doi.org/10.1002/rmv.706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256278/
https://www.ncbi.nlm.nih.gov/pubmed/21905149
http://dx.doi.org/10.1002/rmv.706

Ejemplares similares